BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24663216)

  • 1. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.
    Male V; Nisoli I; Kostrzewski T; Allan DS; Carlyle JR; Lord GM; Wack A; Brady HJ
    J Exp Med; 2014 Apr; 211(4):635-42. PubMed ID: 24663216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.
    Gascoyne DM; Long E; Veiga-Fernandes H; de Boer J; Williams O; Seddon B; Coles M; Kioussis D; Brady HJ
    Nat Immunol; 2009 Oct; 10(10):1118-24. PubMed ID: 19749763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirement for Nfil3 during NK cell development.
    Seillet C; Huntington ND; Gangatirkar P; Axelsson E; Minnich M; Brady HJ; Busslinger M; Smyth MJ; Belz GT; Carotta S
    J Immunol; 2014 Mar; 192(6):2667-76. PubMed ID: 24532575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development.
    Kostrzewski T; Borg AJ; Meng Y; Filipovic I; Male V; Wack A; DiMaggio PA; Brady HJM
    J Immunol; 2018 Feb; 200(4):1370-1381. PubMed ID: 29311361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoter.
    Xu X; Zhou Y; Fu B; Zhang J; Dong Z; Zhang X; Shen N; Sun R; Tian Z; Wei H
    FASEB J; 2020 May; 34(5):6479-6492. PubMed ID: 32190943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development.
    Crotta S; Gkioka A; Male V; Duarte JH; Davidson S; Nisoli I; Brady HJ; Wack A
    J Immunol; 2014 Mar; 192(6):2677-88. PubMed ID: 24534532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
    Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nfil3-independent lineage maintenance and antiviral response of natural killer cells.
    Firth MA; Madera S; Beaulieu AM; Gasteiger G; Castillo EF; Schluns KS; Kubo M; Rothman PB; Vivier E; Sun JC
    J Exp Med; 2013 Dec; 210(13):2981-90. PubMed ID: 24277151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.
    Kamizono S; Duncan GS; Seidel MG; Morimoto A; Hamada K; Grosveld G; Akashi K; Lind EF; Haight JP; Ohashi PS; Look AT; Mak TW
    J Exp Med; 2009 Dec; 206(13):2977-86. PubMed ID: 19995955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet.
    Li D; Wang Y; Yang M; Dong Z
    Cell Death Differ; 2021 Jun; 28(6):1900-1909. PubMed ID: 33462410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.
    Fujimoto S; Ikawa T; Kina T; Yokota Y
    Int Immunol; 2007 Oct; 19(10):1175-82. PubMed ID: 17698981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.
    Kiekens L; Van Loocke W; Taveirne S; Wahlen S; Persyn E; Van Ammel E; De Vos Z; Matthys P; Van Nieuwerburgh F; Taghon T; Van Vlierberghe P; Vandekerckhove B; Leclercq G
    Front Immunol; 2021; 12():732511. PubMed ID: 34630413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
    Tang PM; Zhou S; Meng XM; Wang QM; Li CJ; Lian GY; Huang XR; Tang YJ; Guan XY; Yan BP; To KF; Lan HY
    Nat Commun; 2017 Mar; 8():14677. PubMed ID: 28262747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness.
    Yang M; Li D; Chang Z; Yang Z; Tian Z; Dong Z
    J Exp Med; 2015 Feb; 212(2):253-65. PubMed ID: 25624444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.
    Gabrielli S; Sun M; Bell A; Zook EC; de Pooter RF; Zamai L; Kee BL
    Eur J Immunol; 2017 May; 47(5):800-805. PubMed ID: 28276053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity.
    Boos MD; Yokota Y; Eberl G; Kee BL
    J Exp Med; 2007 May; 204(5):1119-30. PubMed ID: 17452521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
    Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
    Daussy C; Faure F; Mayol K; Viel S; Gasteiger G; Charrier E; Bienvenu J; Henry T; Debien E; Hasan UA; Marvel J; Yoh K; Takahashi S; Prinz I; de Bernard S; Buffat L; Walzer T
    J Exp Med; 2014 Mar; 211(3):563-77. PubMed ID: 24516120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors.
    Xu W; Domingues RG; Fonseca-Pereira D; Ferreira M; Ribeiro H; Lopez-Lastra S; Motomura Y; Moreira-Santos L; Bihl F; Braud V; Kee B; Brady H; Coles MC; Vosshenrich C; Kubo M; Di Santo JP; Veiga-Fernandes H
    Cell Rep; 2015 Mar; 10(12):2043-54. PubMed ID: 25801035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development.
    Schotte R; Dontje W; Nagasawa M; Yasuda Y; Bakker AQ; Spits H; Blom B
    J Immunol; 2010 Jun; 184(12):6670-9. PubMed ID: 20483740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.